Related Experiment Videos
Estrogen use and myocardial infarction risk: a case-control study.
Preventive Medicine
|September 1, 1984
Summary
Estrogen use may reduce myocardial infarction risk in postmenopausal women, particularly those with surgical menopause. Further research is needed to confirm these findings for coronary heart disease prevention.
Area of Science:
- Cardiovascular disease research
- Hormone replacement therapy studies
Background:
- Postmenopausal hormone therapy is widely used.
- Estrogen's role in cardiovascular health remains debated.
- Previous studies suggest potential cardioprotective effects of estrogen.
Purpose of the Study:
- To investigate the association between estrogen use and myocardial infarction (MI) risk.
- To explore potential interactions between estrogen use and menopausal status.
- To analyze estrogen's effect on coronary heart disease (CHD) in postmenopausal women.
Main Methods:
- Case-control study design.
- Inclusion of 39 matched sets (33 pairs, 6 triplets) of postmenopausal white women.
- Statistical adjustment for cardiovascular disease, smoking, education, and menopausal type.
Main Results:
- Unadjusted relative odds ratio (RO) for estrogen use was 0.83.
- Adjusted net RO for estrogen use was 0.61.
- A significant protective effect was observed in women with surgical menopause (net RO 0.37).
Conclusions:
- Estrogen use may be associated with a reduced risk of MI in postmenopausal women.
- The protective effect appears more pronounced in women with surgical menopause.
- Findings suggest estrogen therapy might offer protection against CHD, especially in surgically menopausal women.